| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Jean S Marshall | Q60329463 |
| P2093 | author name string | Jean S Marshall | |
| P2860 | cites work | Comparative aspects of mast cell heterogeneity in different species and sites | Q59883362 |
| Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis | Q64449680 | ||
| Non-pancreatic proteases of the chymotrypsin family. II. Two proteases from a mouse mast cell tumor | Q67251797 | ||
| Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and antirheumatic therapy | Q68028257 | ||
| Replication of murine cytomegalovirus in mast cells | Q68490149 | ||
| Mast cells and necrosis | Q68558990 | ||
| Staphylococcus aureus in atopic dermatitis and in nonatopic dermatitis | Q68607162 | ||
| Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis | Q69032163 | ||
| Defective protective capacity of W/Wv mice against Strongyloides ratti infection and its reconstitution with bone marrow cells | Q69906071 | ||
| Nature of the thymus dependency of mucosal mast cells. III. Mucosal mast cells in nude mice and nude rats, in B rats and in a child with the Di George syndrome | Q70728431 | ||
| A critical role for stem cell factor and c-kit in host protective immunity to an intestinal helminth | Q71163028 | ||
| Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhage | Q71473176 | ||
| Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells | Q71622380 | ||
| Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes | Q71740206 | ||
| Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha | Q71828313 | ||
| Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo | Q73100796 | ||
| TGF-beta1 inhibits the release of histamine and tumor necrosis factor-alpha from mast cells through an autocrine pathway | Q73155736 | ||
| Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression | Q73182317 | ||
| A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation | Q73306812 | ||
| Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model | Q73462928 | ||
| Chymase is a potent chemoattractant for human monocytes and neutrophils | Q73687714 | ||
| Interleukin-4 induces a switch of human intestinal mast cells from proinflammatory cells to Th2-type cells | Q73765736 | ||
| Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha | Q73910743 | ||
| Human mast cell tryptase stimulates the release of an IL-8-dependent neutrophil chemotactic activity from human umbilical vein endothelial cells (HUVEC) | Q73968538 | ||
| Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites | Q74336756 | ||
| IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma | Q77357418 | ||
| MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation | Q78014788 | ||
| Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 | Q24310398 | ||
| Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R | Q24673057 | ||
| Dengue virus selectively induces human mast cell chemokine production | Q24673736 | ||
| Distinct expression and function of the novel mouse chemokine monocyte chemotactic protein-5 in lung allergic inflammation | Q24676896 | ||
| Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line | Q27469685 | ||
| Mast cells as initiators of immunity and host defense | Q28199723 | ||
| Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4 | Q28513447 | ||
| Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48 | Q28574579 | ||
| Delayed onset of inflammation in protease-activated receptor-2-deficient mice | Q30306428 | ||
| Evaluation of the substrate specificity of human mast cell tryptase beta I and demonstration of its importance in bacterial infections of the lung | Q30666014 | ||
| Mast cells as sentinels of innate immunity | Q33536530 | ||
| Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. | Q33591087 | ||
| Human Mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro | Q33848931 | ||
| Mast cells: a cellular link between autoantibodies and inflammatory arthritis | Q34148153 | ||
| The other side of the coin: the protective role of the TH2 cytokines. | Q34245736 | ||
| Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide | Q34531494 | ||
| Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves | Q34619882 | ||
| Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation | Q35037787 | ||
| Host-parasite interactions in rodent nematode infections | Q35131011 | ||
| Mast cells disrupt epithelial barrier function during enteric nematode infection | Q35146757 | ||
| Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis | Q35198652 | ||
| The persisting (P) cell: histamine content, regulation by a T cell-derived factor, origin from a bone marrow precursor, and relationship to mast cells | Q35306832 | ||
| Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release | Q35586919 | ||
| Two types of human mast cells that have distinct neutral protease compositions | Q35611922 | ||
| The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype | Q36230164 | ||
| Generation of leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow | Q36306418 | ||
| IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells | Q36347367 | ||
| Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosa | Q36350812 | ||
| Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines | Q36356540 | ||
| Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo | Q36366794 | ||
| Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists | Q36370341 | ||
| T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro | Q36375111 | ||
| T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. | Q36376120 | ||
| The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells | Q36401371 | ||
| Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. | Q48230335 | ||
| Elimination of a primary schistosome infection from rats coincides with elevated IgE titres and mast cell degranulation. | Q50966317 | ||
| RANTES in human allergen-induced rhinitis: cellular source and relation to tissue eosinophilia. | Q52044225 | ||
| Human leukaemic (HMC-1) and normal skin mast cells express beta 2-integrins: characterization of beta 2-integrins and ICAM-1 on HMC-1 cells. | Q53000340 | ||
| Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. | Q54319446 | ||
| Inability of genetically mast cell-deficient W/Wv mice to acquire resistance against larval Haemaphysalis longicornis ticks. | Q54446547 | ||
| Generation of leukotriene B4 by human lung fragments and purified human lung mast cells. | Q54754618 | ||
| Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and Fc RI | Q57273178 | ||
| Impaired mast cell-dependent natural immunity in complement C3-deficient mice | Q59049556 | ||
| Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores | Q59052484 | ||
| Critical protective role of mast cells in a model of acute septic peritonitis | Q59072203 | ||
| Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α | Q59092114 | ||
| Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression | Q36401802 | ||
| The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. | Q36416493 | ||
| Delayed expulsion of adult Trichinella spiralis by mast cell-deficient W/Wv mice | Q37110194 | ||
| IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production | Q37249746 | ||
| Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells | Q37352170 | ||
| Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor | Q37552904 | ||
| Mast cells as a source of multifunctional cytokines | Q37781952 | ||
| The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions | Q38173964 | ||
| TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells | Q38339799 | ||
| Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. | Q39177814 | ||
| Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells | Q39499091 | ||
| Purification of an atypical mast cell protease and its levels in developing rats | Q39627384 | ||
| Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa | Q39707033 | ||
| Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity | Q39737899 | ||
| Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production | Q40573627 | ||
| Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli | Q40578879 | ||
| Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells. | Q40602074 | ||
| IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells | Q40624585 | ||
| Pseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1 alpha and beta | Q40698972 | ||
| Proteinase-activated receptor (PAR)-1 and -2 agonists induce mediator release from mast cells by pathways distinct from PAR-1 and PAR-2. | Q40716812 | ||
| Mucosal type mast cells express complement receptor type 2 (CD21). | Q40732437 | ||
| Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications | Q40824179 | ||
| Th2-mediated host protective immunity to intestinal nematode infections | Q40840830 | ||
| Mast cell chymase and tryptase during tissue turnover: analysis on in vitro mitogenesis of fibroblasts and keratinocytes and alterations in cutaneous scars | Q40944914 | ||
| IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1. | Q41197635 | ||
| Leukemia inhibitory factor production by rat mast cells | Q41529662 | ||
| Long term increase of mucosal mast cells in the rat induced by administration of Compound 48/80 | Q41730054 | ||
| Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. | Q42118586 | ||
| Unique Functional Characteristics of Mucosal Mast Cells | Q42243361 | ||
| IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. | Q43545333 | ||
| Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines | Q44119028 | ||
| Extensive mast cell degranulation in bovine respiratory syncytial virus-associated paroxystic respiratory distress syndrome | Q44233780 | ||
| Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. | Q44306884 | ||
| Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells | Q44316011 | ||
| Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells | Q44387957 | ||
| Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis | Q44602473 | ||
| Mucosal mast cells are functionally active during spontaneous expulsion of intestinal nematode infections in rat. | Q44624400 | ||
| Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection | Q44640663 | ||
| Comparative cytokine profile of human skin mast cells from two compartments--strong resemblance with monocytes at baseline but induction of IL-5 by IL-4 priming | Q44666492 | ||
| Mast cell-mediated inflammatory responses require the alpha 2 beta 1 integrin | Q44673847 | ||
| FcepsilonRI-dependent gene expression in human mast cells is differentially controlled by T helper type 2 cytokines | Q44681522 | ||
| IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis | Q44714987 | ||
| Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells | Q44715236 | ||
| HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. | Q44787579 | ||
| Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis | Q44969608 | ||
| Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing | Q45750086 | ||
| Virus-induced increases in airway mast cells in brown Norway rats are associated with enhanced pulmonary viral replication and persisting lymphocytic infiltration | Q45785309 | ||
| The role of mast cells in virus-induced inflammation in the murine central nervous system | Q45796403 | ||
| Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. | Q47229699 | ||
| Tyk2 is essential for IFN-alpha-induced gene expression in mast cells | Q47421067 | ||
| Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3. | Q48083987 | ||
| P433 | issue | 10 | |
| P921 | main subject | mast cell | Q191989 |
| P304 | page(s) | 787-799 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Nature Reviews Immunology | Q43355 |
| P1476 | title | Mast-cell responses to pathogens | |
| P478 | volume | 4 |
| Q38779538 | A 21-35 kDa Mixed Protein Component from Helicobacter pylori Activates Mast Cells Effectively in Chronic Spontaneous Urticaria |
| Q50208141 | A New Image Analysis Method Based on Morphometric and Fractal Parameters for Rapid Evaluation of In Situ Mammalian Mast Cell Status |
| Q21131207 | A Temporal Model of Human IgE and IgG Antibody Function |
| Q46517082 | A novel (TG)n(GA)m repeat polymorphism 254 bp downstream of the mast cell chymase (CMA1) gene is associated with atopic asthma and total serum IgE levels |
| Q34565634 | A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses |
| Q34978951 | A novel fungus concentration-dependent rat model for acute invasive fungal rhinosinusitis: an experimental study |
| Q34476441 | Adapters in the organization of mast cell signaling |
| Q24322497 | Adaptors discriminate mast-cell cytokine production from eicosanoid production and degranulation |
| Q55408051 | Adenine attenuates lipopolysaccharide-induced inflammatory reactions. |
| Q41682122 | Advanced glycation end products (AGEs) activate mast cells |
| Q37665290 | Advances in mast cell biology: new understanding of heterogeneity and function |
| Q36197386 | Age-Related Cataract Is Associated with Elevated Serum Immunoglobulin E Levels in the South Korean Population: A Cross-Sectional Study |
| Q36720761 | Aged lymphatic contractility: recent answers and new questions |
| Q36309258 | Aging-associated shifts in functional status of mast cells located by adult and aged mesenteric lymphatic vessels |
| Q51278150 | Allergin-1 inhibits TLR2-mediated mast cell activation and suppresses dermatitis. |
| Q37259631 | Amplification mechanisms for the enhancement of antigen-mediated mast cell activation |
| Q64973338 | An overview of mast cell pattern recognition receptors. |
| Q93165211 | Analysis of Mrgprb2 Receptor-Evoked Ca 2+ Signaling in Bone Marrow Derived (BMMC) and Peritoneal (PMC) Mast Cells of TRPC-Deficient Mice |
| Q35328528 | Anaplasma phagocytophilum infects mast cells via alpha1,3-fucosylated but not sialylated glycans and inhibits IgE-mediated cytokine production and histamine release |
| Q40067512 | Antibodies against nonstructural protein 1 protect mice from dengue virus-induced mast cell activation |
| Q26739741 | Antimicrobial Activity of Mast Cells: Role and Relevance of Extracellular DNA Traps |
| Q35186951 | Apoptosis and pro-inflammatory cytokine response of mast cells induced by influenza A viruses |
| Q36131729 | Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor |
| Q42856690 | BLT2 Is Upregulated in Allergen-Stimulated Mast Cells and Mediates the Synthesis of Th2 Cytokines |
| Q33582849 | Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation |
| Q33744155 | Biological implications of preformed mast cell mediators |
| Q36103499 | Brain mast cell relationship to neurovasculature during development |
| Q30484650 | Brain mast cells link the immune system to anxiety-like behavior |
| Q34011657 | Btk-dependent Rac activation and actin rearrangement following FcepsilonRI aggregation promotes enhanced chemotactic responses of mast cells |
| Q38852257 | C-kit mutations determine dasatinib mechanism of action in HMC-1 neoplastic mast cells: dasatinib differently regulates PKCδ translocation in HMC-1(560) and HMC-1(560,816) cell lines |
| Q33948890 | CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells |
| Q53275729 | Caffeic acid phenethyl ester promotes anti-inflammatory effects by inhibiting MAPK and NF-κB signaling in activated HMC-1 human mast cells. |
| Q35836675 | Carbon-fiber microelectrode amperometry reveals sickle-cell-induced inflammation and chronic morphine effects on single mast cells |
| Q36395739 | Cardiac anaphylaxis: pathophysiology and therapeutic perspectives |
| Q37159942 | Cell-based phenotypic screening of mast cell degranulation unveils kinetic perturbations of agents targeting phosphorylation |
| Q36823119 | Changing paradigms in the immunological science of allergy |
| Q47719808 | Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3. |
| Q35880228 | Chemotactic action of prostaglandin E2 on mouse mast cells acting via the PGE2 receptor 3. |
| Q64250051 | Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine Adjuvant |
| Q35742603 | Chronic Insulin Exposure Induces ER Stress and Lipid Body Accumulation in Mast Cells at the Expense of Their Secretory Degranulation Response |
| Q36641134 | Cigarette smoke suppresses the surface expression of c-kit and FcεRI on mast cells |
| Q36229245 | Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation |
| Q45382363 | Co-administration of inactivated avian influenza virus with CpG or rIL-2 strongly enhances the local immune response after intranasal immunization in chicken |
| Q37864550 | Cognate interactions between mast cells and helper T lymphocytes |
| Q37016261 | Contributions to the study of Trichinella spiralis TSL-1 antigens in host immunity |
| Q53523151 | Cross-platform gene expression signature of human spermatogenic failure reveals inflammatory-like response. |
| Q36508899 | Crosstalk between the alpha2beta1 integrin and c-met/HGF-R regulates innate immunity |
| Q38007005 | Current state of biology and diagnosis of clonal mast cell diseases in adults. |
| Q36791889 | Deciphering new molecular mechanisms of mast cell activation |
| Q90300272 | Decoding communication patterns of the innate immune system by quantitative proteomics |
| Q53736876 | Dermal mast cells reduce progressive tissue necrosis caused by subcutaneous infection with Streptococcus pyogenes in mice |
| Q50033547 | Different potency of bacterial antigens TLR2 and TLR4 ligands in stimulating mature mast cells to cysteinyl leukotriene synthesis |
| Q41494236 | Differential TLR-induced cytokine production by human mast cells is amplified by FcɛRI triggering. |
| Q46215369 | Differential activation of mast cells by antigens from Trichinella spiralis muscle larvae, adults, and newborn larvae. |
| Q40215241 | Distinct roles of Ca2+ mobilization and G protein usage on regulation of Toll-like receptor function in human and murine mast cells |
| Q50266773 | Distribution patterns of mast cells in the uterus of pregnant Meishan pigs |
| Q57484684 | Effect of a Mucoadhesive Gel and Dental Scaling on Gingivitis in Dogs |
| Q41197362 | Effects of C18 Fatty Acids on Intracellular Ca(2+) Mobilization and Histamine Release in RBL-2H3 Cells |
| Q33722001 | Effects of IL-3 and SCF on Histamine Production Kinetics and Cell Phenotype in Rat Bone Marrow-derived Mast Cells |
| Q50284433 | Elevated Systemic Levels of Eosinophil, Neutrophil, and Mast Cell Granular Proteins in Strongyloides Stercoralis Infection that Diminish following Treatment |
| Q33578904 | Elevated levels of vascular endothelial growth factor (VEGF) and soluble vascular endothelial growth factor receptor (VEGFR)-2 in human malaria |
| Q38774563 | Emerging concepts: mast cell involvement in allergic diseases. |
| Q26825467 | Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases |
| Q36087071 | Epidermal Neuromedin U Attenuates IgE-Mediated Allergic Skin Inflammation |
| Q47119776 | Epigenetic and transcriptional control of mast cell responses |
| Q38816119 | Evaluation of myeloid cells (tumor-associated tissue eosinophils and mast cells) infiltration in different grades of oral squamous cell carcinoma |
| Q42661277 | Evidence that integrin alpha IIb beta 3-dependent interaction of mast cells with fibrinogen exacerbates chronic inflammation |
| Q35377612 | Examination of the role of TRPM8 in human mast cell activation and its relevance to the etiology of cold-induced urticaria |
| Q85502336 | Expression and functional characterization of retinoic acid-inducible gene-I-like receptors of mast cells in response to viral infection |
| Q34277321 | Expression of DP2 (CRTh2), a prostaglandin D₂ receptor, in human mast cells |
| Q38162418 | Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity |
| Q35849299 | FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells |
| Q37278664 | FcepsilonRI-induced activation by low antigen concentrations results in nuclear signals in the absence of degranulation |
| Q89994640 | Future Needs in Mast Cell Biology |
| Q36168847 | G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation |
| Q91688122 | Genomic and Bioinformatic Characterization of Mouse Mast Cells (P815) Upon Different Influenza A Virus (H1N1, H5N1, and H7N2) Infections |
| Q40114005 | Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin. |
| Q42144752 | Granzyme D is a novel murine mast cell protease that is highly induced by multiple pathways of mast cell activation |
| Q26824638 | Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation |
| Q35177877 | Heparanase affects secretory granule homeostasis of murine mast cells through degrading heparin |
| Q28534541 | Histamine from brain resident MAST cells promotes wakefulness and modulates behavioral states |
| Q35895041 | Histamine release and surface CD200R1 staining as sensitive methods for assessing murine mast cell activation |
| Q38758968 | Hypoxia Modulates the Response of Mast Cells to Staphylococcus aureus Infection |
| Q54437625 | IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. |
| Q57273112 | IL-33 can promote survival, adhesion and cytokine production in human mast cells |
| Q36621030 | IL-6 and IL-17A degradation by mast cells is mediated by a serglycin:serine protease axis |
| Q38478069 | Identification of a prostaglandin D2 metabolite as a neuritogenesis enhancer targeting the TRPV1 ion channel |
| Q33914055 | Identification of mast cell progenitors in adult mice |
| Q33646084 | Identification of microRNAs regulating the developmental pathways of bone marrow derived mast cells |
| Q29994840 | Imaging protective mast cells in living mice during severe contact hypersensitivity |
| Q37989832 | Immune mediators of postoperative ileus |
| Q52658037 | Immunology Guides Skeletal Muscle Regeneration. |
| Q33822345 | Immunomodulatory Effects of Nanoparticles on Skin Allergy |
| Q38085051 | Immunopathogenesis of allergic disorders: current concepts |
| Q51811548 | Impact of Inflammation and Anti-inflammatory Modalities on Skeletal Muscle Healing: From Fundamental Research to the Clinic. |
| Q34300714 | In vivo roles of factor XII. |
| Q34575244 | Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4. |
| Q43745920 | Increased mast cell density during the infection with velogenic Newcastle disease virus in chickens |
| Q50966996 | Increased percentage of mast cells within sinonasal mucosa of chronic rhinosinusitis with nasal polyp patients independent of atopy. |
| Q46243322 | Induction of Human Lung Mast Cell Apoptosis by Granule Permeabilization: A Novel Approach for Targeting Mast Cells |
| Q33516501 | Infection of mast cells with live streptococci causes a toll-like receptor 2- and cell-cell contact-dependent cytokine and chemokine response |
| Q35139015 | Infiltrating mast cells correlate with angiogenesis in bone metastases from gastric cancer patients |
| Q36788220 | Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling |
| Q34089519 | Influence of the Chungkookjang on histamine-induced wheal and flare skin response: a randomized, double-blind, placebo controlled trial |
| Q37580796 | Influenza A Viruses Replicate Productively in Mouse Mastocytoma Cells (P815) and Trigger Pro-inflammatory Cytokine and Chemokine Production through TLR3 Signaling Pathway |
| Q87412134 | Inhibiting mast cell degranulation by HO-1 affects dendritic cell maturation in vitro |
| Q41018677 | Inhibitory effect of a new orally active cedrol-loaded nanostructured lipid carrier on compound 48/80-induced mast cell degranulation and anaphylactic shock in mice |
| Q39856902 | Inhibitory effect of glycoprotein isolated from Cudrania tricuspidata bureau on expression of inflammation-related cytokine in bisphenol A-treated HMC-1 cells |
| Q54272410 | Inhibitory effect of oblongifolin C on allergic inflammation through the suppression of mast cell activation. |
| Q43041337 | Inhibitory effects of Paeonia suffruticosa on allergic reactions by inhibiting the NF-kappaB/I kappaB-alpha signaling pathway and phosphorylation of ERK in an animal model and human mast cells |
| Q39592545 | Inhibitory effects of chelidonic acid on IL-6 production by blocking NF-κB and caspase-1 in HMC-1 cells |
| Q52653056 | Inhibitory effects of methamphetamine on mast cell activation and cytokine/chemokine production stimulated by lipopolysaccharide in C57BL/6J mice. |
| Q37600200 | Innate cells and T helper 2 cell immunity in airway inflammation |
| Q36392833 | Integrated signalling pathways for mast-cell activation |
| Q34618595 | Interaction between the intestinal immune system and commensal bacteria and its effect on the regulation of allergic reactions |
| Q24673592 | Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract |
| Q57339917 | Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA |
| Q64246397 | Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis |
| Q54444827 | Intracellular RNA recognition pathway activates strong anti-viral response in human mast cells. |
| Q61796951 | Japanese encephalitis virus neuropenetrance is driven by mast cell chymase |
| Q36668282 | LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTP |
| Q36972471 | Leukocytes in glomerular injury |
| Q46506454 | Leukotriene B4 Receptor 2 Is Critical for the Synthesis of Vascular Endothelial Growth Factor in Allergen-Stimulated Mast Cells |
| Q42971326 | Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors |
| Q38457553 | Limited replication of influenza A virus in human mast cells |
| Q34315032 | Lipid body accumulation alters calcium signaling dynamics in immune cells. |
| Q42860261 | Lipopolysaccharide from Porphyromonas gingivalis stimulates rat mast cells to cysteinyl leukotriene generation and upregulates Toll-like receptor -2 and -4 expression. |
| Q51761767 | Lipopolysaccharide inhalation exacerbates allergic airway inflammation by activating mast cells and promoting Th2 responses. |
| Q40178324 | Lipopolysaccharide/TLR4 Stimulates IL-13 Production through a MyD88-BLT2-Linked Cascade in Mast Cells, Potentially Contributing to the Allergic Response |
| Q45996878 | Lipoteichoic acid improves the capability of mast cells in the host defense system against bacteria. |
| Q34608421 | Listeria monocytogenes alters mast cell phenotype, mediator and osteopontin secretion in a listeriolysin-dependent manner |
| Q37030043 | Live Staphylococcus aureus Induces Expression and Release of Vascular Endothelial Growth Factor in Terminally Differentiated Mouse Mast Cells |
| Q38706559 | Long-term survival of the mouse ES cell-derived mast cell, MEDMC-BRC6, in mast cell-deficient Kitw-sh/w-sh mice |
| Q60922370 | MRGPR-mediated activation of local mast cells clears cutaneous bacterial infection and protects against reinfection |
| Q64109694 | Mast Cell Cytonemes as a Defense Mechanism against Coxiella burnetii |
| Q64069849 | Mast Cell Neural Interactions in Health and Disease |
| Q26743796 | Mast Cell-Targeted Strategies in Cancer Therapy |
| Q26771463 | Mast Cell: A Multi-Functional Master Cell |
| Q38008374 | Mast Cells Respond to Cell Injury through the Recognition of IL-33. |
| Q57457168 | Mast Cells and the Adaptive Immune Response |
| Q36013705 | Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy? |
| Q90079376 | Mast Cells as Potential Accelerators of Human Atherosclerosis-From Early to Late Lesions |
| Q28071892 | Mast Cells: Key Players in the Shadow in Oral Inflammation and in Squamous Cell Carcinoma of the Oral Cavity |
| Q35017864 | Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion |
| Q36627796 | Mast cell TNF receptors regulate responses to Mycoplasma pneumoniae in surfactant protein A (SP-A)-/- mice |
| Q54506193 | Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction. |
| Q33344247 | Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor |
| Q33663940 | Mast cell and T cell communication; amplification and control of adaptive immunity |
| Q64100320 | Mast cell degranulation impairs pneumococcus clearance in mice via IL-6 dependent and TNF-α independent mechanisms |
| Q50248557 | Mast cell degranulation in human periodontitis |
| Q39163000 | Mast cell disorders in Ehlers-Danlos syndrome. |
| Q34281728 | Mast cell function is not altered by Coronin-1A deficiency |
| Q34430917 | Mast cell function: a new vision of an old cell |
| Q51497827 | Mast cell histamine-mediated transient inflammation following exposure to nickel promotes nickel allergy in mice. |
| Q42652775 | Mast cell involvement in glucose tolerance impairment caused by chronic mild stress with sleep disturbance |
| Q45185648 | Mast cell mediated inflammatory response in chickens after infection with very virulent infectious bursal disease virus |
| Q35077675 | Mast cell mediator responses and their suppression by pathogenic and commensal microorganisms |
| Q34482185 | Mast cell plasticity and sphingosine-1-phosphate in immunity, inflammation and cancer |
| Q28084141 | Mast cell production and response to IL-4 and IL-13 |
| Q35182662 | Mast cell secretory granules: armed for battle |
| Q33680300 | Mast cell survival and mediator secretion in response to hypoxia |
| Q38008359 | Mast cell synapses and exosomes: membrane contacts for information exchange |
| Q35804444 | Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice |
| Q37653928 | Mast cell-directed recruitment of MHC class II positive cells and eosinophils towards mesenteric lymphatic vessels in adulthood and elderly |
| Q40152339 | Mast cell-macrophage dynamics in modulation of dengue virus infection in skin |
| Q50068940 | Mast cell-neural interactions contribute to pain and itch |
| Q34579554 | Mast cell/IL-4 control of Francisella tularensis replication and host cell death is associated with increased ATP production and phagosomal acidification |
| Q37832440 | Mast cell: insight into remodeling a tumor microenvironment |
| Q34242052 | Mast cells act as phagocytes against the periodontopathogen Aggregatibacter actinomycetemcomitans. |
| Q36819886 | Mast cells and inflammatory kidney disease. |
| Q35106076 | Mast cells and metabolic syndrome |
| Q38723163 | Mast cells and their activation in lung disease |
| Q37151088 | Mast cells are necessary for the hypothermic response to LPS-induced sepsis |
| Q33578155 | Mast cells are permissive for rhinovirus replication: potential implications for asthma exacerbations |
| Q35927571 | Mast cells as cellular sensors in inflammation and immunity |
| Q36819878 | Mast cells as modulators of T-cell responses |
| Q30434434 | Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues |
| Q34619598 | Mast cells can promote the development of multiple features of chronic asthma in mice |
| Q44028110 | Mast cells can regulate skeletal muscle cell proliferation by multiple mechanisms |
| Q35844445 | Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1 |
| Q33928533 | Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria |
| Q61213205 | Mast cells form antibody-dependent degranulatory synapse for dedicated secretion and defence. |
| Q36015885 | Mast cells in the development of adaptive immune responses |
| Q36819950 | Mast cells in the promotion and limitation of chronic inflammation. |
| Q36924398 | Mast cells in vulnerable atherosclerotic plaques--a view to a kill. |
| Q35758258 | Mast cells mediate acute kidney injury through the production of TNF. |
| Q39968854 | Mast cells positive to tryptase and tumour-associated macrophages correlate with angiogenesis in locally advanced colorectal cancer patients undergone to surgery |
| Q42245082 | Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice |
| Q38636165 | Mast cells: new therapeutic target in helminth immune modulation |
| Q37006897 | Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. |
| Q34313871 | Measuring Mast Cell Mediator Release |
| Q34292596 | Mefloquine, an anti-malaria agent, causes reactive oxygen species-dependent cell death in mast cells via a secretory granule-mediated pathway |
| Q91741047 | MicroRNA Involvement in Allergic and Non-Allergic Mast Cell Activation |
| Q64966094 | Mitogen-Activated Protein Kinase Signaling Regulates Proteoglycan Composition of Mast Cell Secretory Granules. |
| Q37567557 | Molecular regulation of mast cell development and maturation |
| Q34263777 | Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection |
| Q37401080 | Murine fetal skin-derived cultured mast cells: a useful tool for discovering functions of skin mast cells |
| Q33621811 | NF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharide |
| Q36491849 | NFAT but not NF-kappaB is critical for transcriptional induction of the prosurvival gene A1 after IgE receptor activation in mast cells |
| Q53669881 | NOD1 and NOD2 Interact with the Phagosome Cargo in Mast Cells: A Detailed Morphological Evidence. |
| Q37726711 | Neutrophil extracellular traps: a strategic tactic to defeat pathogens with potential consequences for the host. |
| Q34596183 | New insights into the antimicrobial effect of mast cells against Enterococcus faecalis |
| Q40417177 | No Role for Mast Cells in Obesity-Related Metabolic Dysregulation |
| Q39140591 | Non-apoptotic functions of caspases in myeloid cell differentiation. |
| Q99593443 | Non-lethal Plasmodium yoelii infection drives complex patterns of Th2-type host immunity and mast cell-dependent bacteremia |
| Q41912340 | Novel collectin/C1q receptor mediates mast cell activation and innate immunity |
| Q37716013 | Olopatadine: a drug for allergic conjunctivitis targeting the mast cell. |
| Q30658262 | Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells |
| Q28264939 | Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells |
| Q34175861 | Our perception of the mast cell from Paul Ehrlich to now. |
| Q41854127 | Partial protection against Helicobacter pylori in the absence of mast cells in mice |
| Q36243982 | Pathological role of IL-6 in the experimental allergic bronchial asthma in mice |
| Q37779176 | Pathways for cytokine secretion. |
| Q51276646 | Peroxisome proliferator-activated receptor-β/δ modulates mast cell phenotype. |
| Q37521998 | Physiological and pathophysiological functions of intestinal mast cells |
| Q27009040 | Possible biological and translational significance of mast cells density in colorectal cancer |
| Q37019818 | Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation |
| Q34072594 | Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma |
| Q40974854 | Predomination of IL-17-producing tryptase-positive/chymase-positive mast cells in azoospermic chronic testicular inflammation |
| Q37295072 | Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells |
| Q46063213 | Proceedings of the 2017 National Toxicology Program Satellite Symposium |
| Q34452585 | Prostaglandin E2 activates and utilizes mTORC2 as a central signaling locus for the regulation of mast cell chemotaxis and mediator release |
| Q34222029 | RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection. |
| Q82733628 | Receptor-guided 3D-QSAR approach for the discovery of c-kit tyrosine kinase inhibitors |
| Q39356966 | Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"? |
| Q36946043 | Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense. |
| Q44213121 | Reduced mucosal injury of SPF chickens by mast cell stabilization after infection with very virulent infectious bursal disease virus |
| Q36092456 | Regulation of mast cell responses in health and disease |
| Q27318063 | Regulation of motor function and behavior by atypical chemokine receptor 1. |
| Q34503321 | Reliable disease biomarkers characterizing and identifying electrohypersensitivity and multiple chemical sensitivity as two etiopathogenic aspects of a unique pathological disorder |
| Q38019500 | Role and relevance of mast cells in fungal infections |
| Q92733040 | Role of Leukotriene B4 Receptor-2 in Mast Cells in Allergic Airway Inflammation |
| Q61712014 | Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation |
| Q31096289 | Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data |
| Q36388787 | Role of nitric oxide in mast cells: controversies, current knowledge, and future applications |
| Q30157264 | Roles for SH2 and SH3 domains in Lyn kinase association with activated FcepsilonRI in RBL mast cells revealed by patterned surface analysis |
| Q35108311 | Roles of retinoic acid-inducible gene-I-like receptors (RLRs), Toll-like receptor (TLR) 3 and 2'-5' oligoadenylate synthetase as viral recognition receptors on human mast cells in response to viral infection |
| Q35077679 | Salmonella typhimurium impedes innate immunity with a mast-cell-suppressing protein tyrosine phosphatase, SptP. |
| Q39035221 | Secretory lysosomes of mouse mast cells store and exocytose active caspase-3 in a strictly granzyme B dependent manner |
| Q35267999 | Selective, α2β1 integrin-dependent secretion of il-6 by connective tissue mast cells |
| Q37041302 | Serotonin of mast cell origin contributes to hippocampal function |
| Q57810183 | Short-term in vitro culture of purity and highly functional rat bone marrow-derived mast cells |
| Q34061484 | Single-walled carbon nanotube exposure induces membrane rearrangement and suppression of receptor-mediated signalling pathways in model mast cells. |
| Q39228868 | Skin microbiome and mast cells. |
| Q80230644 | Snake bites and bee stings: the mast cell strikes back |
| Q85003606 | Stable Overexpression of miRNAs in Bone Marrow-Derived Murine Mast Cells Using Lentiviral Expression Vectors |
| Q39528464 | Staphylococcus aureus evades the extracellular antimicrobial activity of mast cells by promoting its own uptake |
| Q92474359 | Streptococcal sagA activates a proinflammatory response in mast cells by a sublytic mechanism |
| Q41161520 | Study of the role of "gatekeeper" mutations V654A and T670I of c-kit kinase in the interaction with inhibitors by means mixed molecular dynamics/docking approach |
| Q36836197 | Suppression of an established immune response by UVA--a critical role for mast cells |
| Q36819865 | Synovial mast cells: role in acute and chronic arthritis |
| Q38025397 | TLR signaling in mast cells: common and unique features |
| Q36087376 | TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release |
| Q26784456 | Targeting mast cells in gastric cancer with special reference to bone metastases |
| Q26863340 | Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy |
| Q37848482 | Tec family kinases: regulation of FcεRI-mediated mast-cell activation |
| Q26744486 | Tetraspanins and Transmembrane Adaptor Proteins As Plasma Membrane Organizers-Mast Cell Case |
| Q55104920 | The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury. |
| Q24650702 | The BH3-only protein Puma plays an essential role in cytokine deprivation induced apoptosis of mast cells |
| Q34868949 | The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid |
| Q37577616 | The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell |
| Q64902515 | The Role of Mast Cells in Stroke. |
| Q47130424 | The Role of Mast Cells in Tuberculosis: Orchestrating Innate Immune Crosstalk? |
| Q42198178 | The Role of TRP Proteins in Mast Cells |
| Q34781617 | The SLAM and SAP gene families control innate and adaptive immune responses. |
| Q36989717 | The Vibrio cholerae cytolysin promotes activation of mast cell (T helper 2) cytokine production |
| Q37882106 | The active contribution of Toll-like receptors to allergic airway inflammation. |
| Q35663961 | The chemokine system in innate immunity |
| Q36902820 | The contribution of toll-like receptors to the pathogenesis of asthma |
| Q37505656 | The controversial role of mast cells in tumor growth |
| Q36613696 | The development of allergic inflammation |
| Q88905959 | The development of methods for primary mast cells in vitro and ex vivo: An historical review |
| Q37829600 | The effect of bacterial, viral and fungal infection on mast cell reactivity in the allergic setting |
| Q37798825 | The enteric nervous system as a regulator of intestinal epithelial barrier function in health and disease |
| Q34367655 | The history of mast cell and basophil research - some lessons learnt from the last century |
| Q37010493 | The mast cell and allergic diseases: role in pathogenesis and implications for therapy |
| Q58582556 | The monocyte-macrophage-mast cell axis in dengue pathogenesis |
| Q40147728 | The multiple mechanisms of Ca2+ signalling by listeriolysin O, the cholesterol-dependent cytolysin of Listeria monocytogenes |
| Q53523351 | The novel CGRP receptor antagonist BIBN4096BS alleviates a postoperative intestinal inflammation and prevents postoperative ileus. |
| Q37259584 | The phosphoinositide 3-kinase-dependent activation of Btk is required for optimal eicosanoid production and generation of reactive oxygen species in antigen-stimulated mast cells |
| Q37920779 | The procoagulant and proinflammatory plasma contact system |
| Q43290337 | The protein tyrosine kinase Tec regulates mast cell function |
| Q36825033 | The role of innate immunity in asthma: leads and lessons from mouse models |
| Q34144555 | The role of mast cells and their mediators in reproduction, pregnancy and labour. |
| Q35029612 | The role of mast cells in cancers |
| Q38081099 | The role of mast cells in neuroinflammation |
| Q39257722 | The role of mast cells in oral squamous cell carcinoma |
| Q34206328 | The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo |
| Q37834484 | The significant role of mast cells in cancer |
| Q37158872 | The tyrosine kinase network regulating mast cell activation |
| Q36826524 | Tick Salivary Sialostatin L Represses the Initiation of Immune Responses by Targeting IRF4-Dependent Transcription in Murine Mast Cells. |
| Q92188877 | To Be or Not to Be a Pathogen: Candida albicans and Celiac Disease |
| Q35749630 | Toll-like receptor-MyD88 and Fc receptor pathways of mast cells mediate the thyroid dysfunctions observed during nonthyroidal illness. |
| Q54424235 | Transforming growth factor beta 1 plays an important role in inducing CD4(+)CD25(+)forhead box P3(+) regulatory T cells by mast cells. |
| Q37810915 | Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets |
| Q57339867 | Unimpaired Responses to Vaccination With Protein Antigen Plus Adjuvant in Mice With Kit-Independent Mast Cell Deficiency |
| Q26851822 | Vesicular trafficking and signaling for cytokine and chemokine secretion in mast cells |
| Q26767293 | Years in Review: Recent Progress in Cellular Allergology |
| Q84582191 | [Pulmonary allergic reactions] |
| Q35631301 | mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells |
| Q35759111 | rPbPga1 from Paracoccidioides brasiliensis Activates Mast Cells and Macrophages via NFkB |
| Q40287757 | α-Hemolysin enhances Staphylococcus aureus internalization and survival within mast cells by modulating the expression of β1 integrin |
Search more.